Login
LabRulez
Registration
Settings
Filter
Filter
Password reset
Password reset
 

Similar PDF

[ TECHNOLOGY BRIEF ]Evaluating BioAccord LC-MS System Performance for Deployment of aCompact, SmartMS-Enabled Biopharma Solution in Late Stage Developmentand QC Environment – Intact Mass AnalysisHenry Shion, Jonathan Pugh, Jill Lord, Yun Alelyunas, Ying Qing Yu and Weibin Chen. Waters Corporation,...
Key words
bioaccord, bioaccordsystem, systeminter, interglycoforms, glycoformsintact, intactfive, fiveintra, intrareproducibility, reproducibilitymajor, majormass, massrsd, rsdstudy, studysystems, systemsbrief, briefabundance
[ TECHNOLOGY BRIEF ]Routine Peptide Mapping Analysis using the BioAccord SystemNilini Ranbaduge, Henry Shion, and Ying Qing YuWaters Corporation, Milford, MA, USASmartMS-enabled BioAccord System improves theoperational efficiency for routine peptide mapping analysis.GOALDemonstrate how the BioAccord™ Systemsimplifies routine peptide mapping analysiswith...
Key words
bioaccord, bioaccordpeptide, peptidemapping, mappingpurposefully, purposefullysystem, systemaccessibility, accessibilityprotein, proteininformatics, informaticssmartms, smartmsintegrated, integratedbrief, briefflr, flrtuv, tuvacquity, acquityunifi
[ TECHNOLOGY BRIEF ]Analysis of Antibody Drug Conjugates (ADCs) by Native Mass Spectrometryon the BioAccord SystemHenry Shion, Ying Qing Yu, and Weibin ChenWaters Corporation, Milford, MA, USADrug-to-Antibody Ratio (DAR) determination of Lys andCys conjugated ADCs was accomplished using analyticalscale size...
Key words
bioaccord, bioaccordconjugated, conjugatedadc, adcdar, daradcs, adcsnative, nativedrug, drugantibody, antibodysystem, systemcovalent, covalentbrief, briefsec, secconjugates, conjugatescysteine, cysteinelysine
Application NoteApplication of a Mass Confirmation Workflowfor Biotherapeutics ScreeningHenry Shion, Scott J. Berger, Ying Qing YuWaters Corporation AbstractIn the study, we report the development of a higher throughput intact mass confirmation workflowusing the BioAccord LC-MS System1-10 operated under the control of...
Key words
native, nativeconfirmation, confirmationmass, massreversed, reversedintact, intactacquity, acquityantibody, antibodyrda, rdathroughput, throughputstatus, statussec, secphase, phasenoncovalent, noncovalentuplc, uplcworkflow
 

Similar PDF

[ TECHNOLOGY BRIEF ]Evaluating BioAccord LC-MS System Performance for Deployment of aCompact, SmartMS-Enabled Biopharma Solution in Late Stage Developmentand QC Environment – Intact Mass AnalysisHenry Shion, Jonathan Pugh, Jill Lord, Yun Alelyunas, Ying Qing Yu and Weibin Chen. Waters Corporation,...
Key words
bioaccord, bioaccordsystem, systeminter, interglycoforms, glycoformsintact, intactfive, fiveintra, intrareproducibility, reproducibilitymajor, majormass, massrsd, rsdstudy, studysystems, systemsbrief, briefabundance
[ TECHNOLOGY BRIEF ]Routine Peptide Mapping Analysis using the BioAccord SystemNilini Ranbaduge, Henry Shion, and Ying Qing YuWaters Corporation, Milford, MA, USASmartMS-enabled BioAccord System improves theoperational efficiency for routine peptide mapping analysis.GOALDemonstrate how the BioAccord™ Systemsimplifies routine peptide mapping analysiswith...
Key words
bioaccord, bioaccordpeptide, peptidemapping, mappingpurposefully, purposefullysystem, systemaccessibility, accessibilityprotein, proteininformatics, informaticssmartms, smartmsintegrated, integratedbrief, briefflr, flrtuv, tuvacquity, acquityunifi
[ TECHNOLOGY BRIEF ]Analysis of Antibody Drug Conjugates (ADCs) by Native Mass Spectrometryon the BioAccord SystemHenry Shion, Ying Qing Yu, and Weibin ChenWaters Corporation, Milford, MA, USADrug-to-Antibody Ratio (DAR) determination of Lys andCys conjugated ADCs was accomplished using analyticalscale size...
Key words
bioaccord, bioaccordconjugated, conjugatedadc, adcdar, daradcs, adcsnative, nativedrug, drugantibody, antibodysystem, systemcovalent, covalentbrief, briefsec, secconjugates, conjugatescysteine, cysteinelysine
Application NoteApplication of a Mass Confirmation Workflowfor Biotherapeutics ScreeningHenry Shion, Scott J. Berger, Ying Qing YuWaters Corporation AbstractIn the study, we report the development of a higher throughput intact mass confirmation workflowusing the BioAccord LC-MS System1-10 operated under the control of...
Key words
native, nativeconfirmation, confirmationmass, massreversed, reversedintact, intactacquity, acquityantibody, antibodyrda, rdathroughput, throughputstatus, statussec, secphase, phasenoncovalent, noncovalentuplc, uplcworkflow
 

Related content

Quantitation of Pesticide Residues in Milk Using the Agilent 6470 Triple Quadrupole LC/MS

Aplikace
| 2021 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Food & Agriculture

Utilization of the ACQUITY PREMIER System and Column for Improved Oligonucleotide Bioanalytical Chromatographic Performance

Aplikace
| 2021 | Waters
Instrumentation
Consumables, LC/MS, LC/MS/MS, LC columns, LC/QQQ
Manufacturer
Waters
Industries
Klinická analýza

Development of Profiling Method for Major Lipids in Blood by Triple Quadrupole LC/MS/MS

Aplikace
| 2021 | Shimadzu
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Klinická analýza
 

Related content

Quantitation of Pesticide Residues in Milk Using the Agilent 6470 Triple Quadrupole LC/MS

Aplikace
| 2021 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Food & Agriculture

Utilization of the ACQUITY PREMIER System and Column for Improved Oligonucleotide Bioanalytical Chromatographic Performance

Aplikace
| 2021 | Waters
Instrumentation
Consumables, LC/MS, LC/MS/MS, LC columns, LC/QQQ
Manufacturer
Waters
Industries
Klinická analýza

Development of Profiling Method for Major Lipids in Blood by Triple Quadrupole LC/MS/MS

Aplikace
| 2021 | Shimadzu
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Shimadzu
Industries
Klinická analýza
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use

LabRulez s.r.o., all rights reserved.